Boardroom Alpha
Start trial
10-Q primary document
PETS · Quarterly Report (Form 10-Q) · Filed August 13, 2026

Petmed Express Inc — 10-Q exhibit

amendmentno1tocampbellem.htm
Petmed Express Inc on Boardroom Alpha
amendmentno1tocampbellem
4936-4559-0698.5 AMENDMENT NO. 1 TO INTERIM EXECUTIVE EMPLOYMENT AGREEMENT This is Amendment No. 1, dated August 10, 2026 (this “Amendment No. 1”), to the Interim Executive Employment Agreement, dated October 25, 2025 (the “Employment Agreement”), between PETMED EXPRESS, INC., a Florida corporation (the “Company”), and LESLIE C. G. CAMPBELL, an individual (the “Executive”). Capitalized terms used in this Amendment No. 1 and not otherwise defined herein shall have the meanings ascribed thereto in the Employment Agreement. Background WHEREAS, pursuant to the terms of the Employment Agreement, Executive is employed as the Interim Chief Executive Officer and President of the Company; and WHEREAS, the Company and the Executive desire to hereby amend Section 3 and Section 4(a) of the Employment Agreement, as set forth below. NOW, THEREFORE, the parties hereto intending to be legally bound hereby, and in consideration of the mutual covenants herein contained, agree as follows: Terms 1. Section 3 of the Employment Agreement is hereby deleted in its entirety and replaced with the following: 3. TERM OF EMPLOYMENT. Executive’s employment commenced on August 11, 2025 and shall continue under this Agreement until terminated in accordance with Section 4 of this Agreement (the “Term of Employment”). 2. Section 4(a) of the Employment Agreement is hereby deleted in its entirety and replaced with the following: (a) At-Will Employment. Executive’s employment by Company is on an “at- will” basis and may be immediately terminated at any time and for any reason (with or without cause) by Company or Executive by delivering written notice of termination to the other party. 3. Except as expressly modified by this Amendment No. 1, all terms and conditions of the Employment Agreement remain in full force and effect in accordance with the terms thereof. 4. This Amendment No. 1 may be executed in one or more counterparts, each of which when executed shall be deemed to be an original but all of which when taken together shall constitute one and the same instrument. Counterparts may be delivered via facsimile, electronic mail (including .pdf or any electronic signature complying with the U.S. federal ESIGN Act of 2000, e.g., www.docusign.com) or other transmission method and any counterpart Docusign Envelope ID: E26CA19C-E76F-8900-8027-308CF01DA743

 
2 4936-4559-0698.5 so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes. 5. This Amendment No. 1, together with the Employment Agreement, contains the final, complete, and exclusive expression of the parties’ understanding and agreement concerning the matters contemplated herein and supersedes any prior or contemporaneous agreement of representation, oral or written, among them. 6. This instrument shall be binding upon, and shall inure to the benefit of, each of the parties’ respective personal representatives, heirs, successors, and assigns. 7. This instrument shall be governed by, and construed and enforced in accordance with the laws of the State of Florida, and any disputes arising hereunder shall be resolved in the manner set forth in Section 10 of the Employment Agreement. [signatures follow] Docusign Envelope ID: E26CA19C-E76F-8900-8027-308CF01DA743

 
3 4936-4559-0698.5 IN WITNESS WHEREOF, the parties have executed this Amendment No. 1 on the day and year first written above. PETMED EXPRESS, INC. By: Name: Robert Lawsky Title: General Counsel EXECUTIVE __________________________________ Leslie C.G. Campbell, individually Docusign Envelope ID: E26CA19C-E76F-8900-8027-308CF01DA743

 
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer